Clinical trial

Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes

NCT06989697

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-01-01

PhasePHASE3

Study timeline

Study start (actual)2025-01-01Date precision: day

Registry last updated2025-05-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabets Mellitusunresolved

Cognitive Ability, Generalunresolved

Interventions

Cilostazol / Ginko Leaf Dried Ext.DRUG

PlaceboDRUG

Sponsors & collaborators

Seoul National University Bundang Hospitallead sponsor

SK Chemicals Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06989697 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.